SCALOP2 trial in pancreatic ca
No benefit from dose escalation to 60Gy (conventional fractionation) or nelfinavir
Hypofractionation now?
#ESTRO2022

Hypofractionation for breast #estro2022

The message was so clear ! No more 25 F for breast N+ cancer #ESTRO2022 . Hypofractionation must be considered for all!

Hypofractionation is the rule in PC #estro2022

Dose escalation to 60Gy in 30 fr didn’t improve PFS or OS in pancreatic cancer. May be not enough dose and need higher with hypofractionation? #estro2022

Proud to present our Navigator-Assisted Hypofractionation ( #NAVAH ) program work in addressing #RadOnc access disparities facing African-American breast cancer patients at #ACRO2023 ! #bcsm #DEI #KillCancer #BlackInMedicine #RepresentationMatters

Day 2 of ESTRO course on Radiobiology excellently clarifying hypofractionation concepts

PACE B 2-year toxicity results presented by Alison Tree 💙🇺🇦: SBRT vs standard hypofractionation. #ESTRO2021 . More grade 2 GU toxicity with SBRT, but still very low. Even lower when you use Cyberknife? Grade 3 toxicity: 0-0.3%

Postoperative radiotherapy for breast cancer: hypofractionation RCR consensus statements.
rcr.ac.uk/publication/po…

All radiation oncologists have a role in #ClimateAction . The 4 R’s in #radonc are a great starting point to learn how the field can lead efforts in this space… this may include further adoption of hypofractionation, telehealth, and virtual conferencing (when appropriate).

So grateful to our mentors + collaborators 🙇🏻‍♀️ but especially proud of 1st author, Dr. Edward Christopher "Chris" Dee, MD🌟Memorial Sloan Kettering Radiation Oncology for this analysis showing ↑ access to #hypofractionation (i.e., shorter RT) may ↓ tx noncompletion disparites in pts w/ localized #bcsm #pcsm
ascopubs.org/doi/10.1200/OP…

Brainstem #Glioma treated with 2.7 Gy*15 Fr. and TMZ 75 mg/m2 in 73 y.o. male. Just 2 cycles of TMZ after RT/CHT ( suspended for low platelet count with a real difficult recover). Moderate hypofractionation seems a reasonable option also for these districts. #radonc

📯 📯 A short tale of HYPOFRACTIONATION in Radiation Oncology 🤫😉

radonc ARRO ASTRO ESTRO OncoAlert

A Delphi consensus on early breast cancer RT treatment strategy published on The Lancet Oncology. Hypofractionation is a standard almost in every setting. Radiobiology of breast cancer has given great satisfaction to #radonc depts. Excellent job and nice end of the year lecture.

Hypofractionation in breast cancer, international trends by income groups. More to be done for knowledge transition from evidence to clinical practice. ⁦Danielle Rodin⁩ ⁦Dr. Fabio Moraes⁩ ⁦Anna Mary Nyakabau⁩ ⁦JCO Global Oncology⁩ ⁦Mary Gospodarowicz⁩ ⁦Fidel Rubagumya , MD, MMed, MPH⁩ ⁦

Attending #ASTRO22 . Hope to see more Hypofractionation this year !

Breast scientific highlight #5. The ATEMPT Phase 2 trial showed safety of concurrent radiation with the newer HER-2 agent, TDM-1 as well as with TH. Hypofractionation had less acute skin toxicity than conventional fractionation. #ASTRO21 #BreastCancer #ASTRO21 SocialChampion

#WeekendScienceWith Clinical Oncology 📢Special issue on hypofractionation! Expertly curated articles by the leaders in the field, including SABR normal tissue dose guidelines TV Ajithkumar Prof Ananya💙 #radonc #sabr ➡️clinicaloncologyonline.net/issue/S0936-65…

🎉Very happy to say that our paper providing an initial estimate of the #CarbonFootprint of #Radiotherapy is now in Physica Medica : sciencedirect.com/science/articl… 🌍

🚘patient travel dominates ➡️time for more hypofractionation?

Long term quality of life analysis of CHHiP trial shows no impact of hypofractionation on QoL for #prostatecancer at 5y. #pcsm #radonc #ASTRO2018 Prof Emma Hall